Abiopharma

New Form 8-K for Quantum-Si Incorporated

Puma Biotechnology, Inc. - Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

New Form 4 - Royalty Pharma plc Filed: 2025-08-08 AccNo: 0001802768-25-000105 Size: 19 KB

New Form 3 - CATALYST PHARMACEUTICALS, INC. Filed: 2025-08-08 AccNo: 0001161697-25-000221 Size: 5 KB

CV Sciences, Inc. To Announce Second Quarter 2025 Results On August 13, 2025

Simulations Plus, Inc. (SLP) Investors Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation

Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

New Form 4 - Royalty Pharma plc Filed: 2025-08-08 AccNo: 0001802768-25-000104 Size: 14 KB

New Form 8-K - Earth Science Tech, Inc. Filed: 2025-08-08 AccNo: 0001641172-25-022803 Size: 244 KB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

New Form 8-K - Quantum-Si Inc Filed: 2025-08-08 AccNo: 0001816431-25-000056 Size: 3 MB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

New Form 4 - Royalty Pharma plc Filed: 2025-08-08 AccNo: 0001802768-25-000103 Size: 18 KB

New Form 4 - OPKO HEALTH, INC. Filed: 2025-08-08 AccNo: 0000950170-25-105971 Size: 15 KB

New Form 8-K - WINDTREE THERAPEUTICS INC /DE/ Filed: 2025-08-08 AccNo: 0001437749-25-025762 Size: 152 KB Item 8.01: Other Events

New Form 4 - Royalty Pharma plc Filed: 2025-08-08 AccNo: 0001802768-25-000102 Size: 5 KB

New Form 4 - Elite Health Systems Inc. Filed: 2025-08-08 AccNo: 0001437749-25-025760 Size: 5 KB